Trial Profile
An Open-Label Study to Evaluate the Effects of Ketoconazole and the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Repeat Doses of Pazopanib in Subjects With Solid Tumor Malignancies.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Esomeprazole; Ketoconazole
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 02 Sep 2011 Actual end date August 2011 added as reported by ClinicalTrials.gov record
- 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.